EXAM ACTUAL FINAL PRACTICE EXAM PREP WITH
ALL POSSIBLE COMPLETE DETAILED AND MOST
TESTED PRACTICE QUESTIONS AND 100% CORRECT
VERIFIED ANSWERS FULLY SOLVED WITH
CERTIFIED RATIONALES PLUS RELIABLE ANSWER
KEY (100% COMPLETE SOLUTIONS) 2026-2027 Q&A
UPDATED VERSION 100% GUARANTEED PASS
INSTANT DOWNLOAD PDF
1. A 68-year-old patient with chronic kidney disease is prescribed gentamicin.
Which pharmacokinetic change places this patient at greatest risk for toxicity?
A. Increased hepatic metabolism
B. Increased protein binding
C. Decreased renal excretion
D. Increased gastrointestinal absorption
Rationale: Gentamicin is primarily eliminated unchanged by the kidneys.
Reduced renal function decreases drug clearance, prolongs the half-life, and
increases serum concentrations, significantly raising the risk of nephrotoxicity
and ototoxicity.
2. Which process describes the movement of a drug from the bloodstream into body
tissues?
A. Absorption
B. Distribution
,C. Metabolism
D. Excretion
Rationale: Distribution is the movement of a drug from systemic circulation into
tissues and body fluids. Factors such as blood flow, protein binding, membrane
permeability, and tissue affinity influence the extent of distribution.
3. Which organ is responsible for the primary metabolism of most medications?
A. Kidney
B. Lung
C. Liver
D. Pancreas
Rationale: The liver contains cytochrome P450 enzymes responsible for Phase I
metabolism and conjugating enzymes responsible for Phase II metabolism.
Hepatic metabolism transforms drugs into more water-soluble forms for
elimination.
4. A patient taking warfarin begins therapy with trimethoprim-sulfamethoxazole.
What is the expected outcome?
A. Decreased anticoagulant effect
B. Increased risk of bleeding
C. No significant drug interaction
D. Reduced renal clearance of warfarin
Rationale: Trimethoprim-sulfamethoxazole inhibits CYP2C9, which metabolizes
warfarin. This inhibition increases warfarin levels, enhancing its anticoagulant
effect and raising the risk of bleeding. Close monitoring of INR is required.
5. An agonist produces its therapeutic effect by:
A. Blocking receptors
B. Activating receptors
C. Destroying receptors
D. Preventing metabolism
Rationale: Agonists bind to receptors and activate them, producing a
physiological response similar to endogenous substances.
,6. A competitive antagonist works by:
A. Destroying receptor sites
B. Competing with agonists for receptor binding
C. Increasing receptor sensitivity
D. Stimulating maximal receptor response
Rationale: Competitive antagonists reversibly occupy receptors without
activating them, preventing agonists from producing their effects.
7. A nurse practitioner explains to a patient that nitroglycerin patches should be
applied in the morning and removed in the evening. This medication schedule
reduces the potential for:
A. Medication tolerance
B. Nitrate tolerance
C. Rebound hypertension
D. Withdrawal symptoms
Rationale: Nitrate tolerance develops with continuous exposure to nitrates. A
nitrate-free interval of 10-12 hours daily, typically achieved by removing the
patch at night, prevents tolerance and maintains therapeutic efficacy.
8. A female patient has been taking prednisone for her asthma for 1 month. The
nurse will teach her to gradually decrease her dose of prednisone to avoid:
A. Adrenal insufficiency
B. Rebound asthma symptoms
C. Cushing's syndrome
D. Hyperglycemia
Rationale: Abrupt withdrawal of corticosteroids after prolonged use can cause
adrenal insufficiency because the body's hypothalamic-pituitary-adrenal axis is
suppressed. Gradual tapering allows adrenal function to recover.
9. The most effective therapy for a patient who is H. pylori positive with a gastric
ulcer is:
A. Amoxicillin, clarithromycin, and omeprazole
B. Bismuth, metronidazole, omeprazole, and tetracycline
, C. Metronidazole, clarithromycin, and lansoprazole
D. Amoxicillin, metronidazole, and famotidine
Rationale: Quadruple therapy with bismuth, metronidazole, omeprazole, and
tetracycline is a first-line regimen for H. pylori eradication, particularly in areas
with high clarithromycin resistance or when penicillin allergy is present.
10. A patient with a recent diagnosis of acute renal failure has a long-standing
seizure disorder which has been successfully controlled for several years with
antiseizure medications. The nurse should recognize that the patient's
compromised renal function will likely:
A. Render the antiseizure medications ineffective
B. Decrease the first-pass effect of the medications
C. Increase the half-life of drugs that are eliminated by the kidneys
D. Require IV administration of the medications to achieve therapeutic effect
Rationale: Impaired renal function will increase the half-life of drugs that are
metabolized and excreted by the kidneys, leading to drug accumulation and
potential toxicity. Dosage adjustments are often required.
11. A patient is treated with an antibiotic for an infection in his leg. After 2 days of
taking the antibiotic, the patient calls the clinic and reports that he has a rash all
over his body. The nurse is aware that a rash can be an adverse effect of an
antibiotic and can be either a biologic, chemical, or physiologic action of the drug,
which is an example of:
A. Pharmacotherapeutics
B. Pharmacodynamics
C. Pharmacokinetics
D. Pharmacogenetics
Rationale: Pharmacodynamics is the study of the biologic, chemical, and
physiologic actions of a particular drug within the body, including both
therapeutic effects and adverse effects.
12. A nurse practitioner is caring for a 70-year-old patient who is taking
desmopressin (DDAVP). The patient has a history of cardiovascular disease. The
nurse will prioritize the assessment of which of the following?